Regulation of angiogenesis by phospholipid lysophosphatidic acid

Frontiers in Bioscience

Volumn 18, Issue 3, 2013, Pages 852-861

  Chen, Yiliang ^a   Ramakrishnan, Devi Prasadh ^a,c   Ren, Bin ^a,b  

^a BLOOD RESEARCH INSTITUTE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; Endothelial Cells; Lysophosphatidic Acid; Review; VEGF

Indexed keywords

EID: 84880398679     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/4148     Document Type: Article

References (64)

1. C Schultz: Challenges in studying phospholipid signaling. Nat Chem Biol 6(7), 473-475 (2010)
2. ME Lin, DR Herr, J Chun: Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance. Prostaglandins Other Lipid Mediat 91(3-4), 130-138 (2010)
3. SS Smyth, HY Cheng, S Miriyala, M Panchatcharam, AJ Morris: Roles of lysophosphatidic acid in cardiovascular physiology and disease. Biochim Biophys Acta 1781(9), 563-570 (2008)
4. GB Mills, WH Moolenaar: The emerging role of lysophosphatidic acid in cancer. Nat Rev Cancer 3(8), 582- 591 (2003) (Pubitemid 37328830)
5. HF Dvorak: Angiogenesis: update 2005. J Thromb Haemost 3(8), 1835-1842 (2005) (Pubitemid 41716570)
6. B Ren, KO Yee, J Lawler, R Khosravi-Far: Regulation of tumor angiogenesis by thrombospondin-1. Biochim Biophys Acta 1765(2), 178-188 (2006)
7. B Ren, Y Deng, A Mukhopadhyay, AA Lanahan, ZW Zhuang, KL Moodie, MJ Mulligan-Kehoe, TV Byzova, RT Peterson, M Simons: ERK1/2-Akt1 crosstalk regulates arteriogenesis in mice and zebrafish. J Clin Invest 120(4), 1217-1228 (2010)
8. H Sumida, K Noguchi, Y Kihara, M Abe, K Yanagida, F Hamano, S Sato, K Tamaki, Y Morishita, MR Kano, C Iwata, K Miyazono, K Sakimura, T Shimizu, S Ishii: LPA4 regulates blood and lymphatic vessel formation during mouse embryogenesis. Blood 116(23), 5060-5070 (2010)
9. W Siess, KJ Zangl, M Essler, M Bauer, R Brandl, C Corrinth, R Bittman, G Tigyi, M Aepfelbacher: Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions. Proc Natl Acad Sci U S A 96(12), 6931-6936 (1999) (Pubitemid 29274987)
10. M Bot, I Bot, R Lopez-Vales, CH van de Lest, JS Saulnier-Blache, JB Helms, S David, TJ van Berkel, EA Biessen: Atherosclerotic lesion progression changes lysophosphatidic acid homeostasis to favor its accumulation. Am J Pathol 176(6), 3073-3084 (2010)
11. JJ Contos, N Fukushima, JA Weiner, D Kaushal, J Chun: Requirement for the lpA1 lysophosphatidic acid receptor gene in normal suckling behavior. Proc Natl Acad Sci U S A97(24), 13384-13389 (2000)
12. X Ye, K Hama, JJ Contos, B Anliker, A Inoue, MK Skinner, H Suzuki, T Amano, G Kennedy, H Arai, J Aoki, J Chun: LPA3-mediated lysophosphatidic acid signalling in embryo implantation and spacing. Nature 435(7038), 104- 108 (2005) (Pubitemid 40655916)
13. M Sahin, E Sahin, S Gumuslu: Cyclooxygenase-2 in cancer and angiogenesis. Angiology 60(2), 242-253 (2009)
14. JJ Contos, I Ishii, N Fukushima, MA Kingsbury, X Ye, S Kawamura, JH Brown, J Chun: Characterization of lpa(2) (Edg4) and lpa(1)/lpa(2) (Edg2/Edg4) lysophosphatidic acid receptor knockout mice: signaling deficits without obvious phenotypic abnormality attributable to lpa(2). Mol Cell Biol 22(19), 6921-6929 (2002)
15. I Garkavtsev, SV Kozin, O Chernova, L Xu, F Winkler, E Brown, GH Barnett, RK Jain: The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis. Nature 428(6980), 328-332 (2004) (Pubitemid 38418804)
16. F Lerebours, S Vacher, C Andrieu, M Espie, M Marty, R Lidereau, I Bieche: NF-kappa B genes have a major role in Inflammatory Breast Cancer. Bmc Cancer 8, 41 (2008)
17. A Boucharaba, B Guillet, F Menaa, M Hneino, AJ van Wijnen, P Clezardin, O Peyruchaud: Bioactive lipids lysophosphatidic acid and sphingosine 1-phosphate mediate breast cancer cell biological functions through distinct mechanisms. Oncol Res 18(4), 173-184 (2009)
18. SU Chen, CH Chou, H Lee, CH Ho, CW Lin, YS Yang: Lysophosphatidic acid up-regulates expression of interleukin-8 and -6 in granulosa-lutein cells through its receptors and nuclear factor-kappaB dependent pathways: implications for angiogenesis of corpus luteum and ovarian hyperstimulation syndrome. J Clin Endocrinol Meta. 93(3), 935-943 (2008) (Pubitemid 351398577)
19. SU Chen, CH Chou, KH Chao, H Lee, CW Lin, HF Lu, YS Yang: Lysophosphatidic acid up-regulates expression of growth-regulated oncogene-alpha, interleukin-8, and monocyte chemoattractant protein-1 in human firsttrimester trophoblasts: possible roles in angiogenesis and immune regulation. Endocrinology 151(1), 369-379 (2010)
20. V Veillat, C Carli, CN Metz, Y Al-Abed, PH Naccache, A Akoum: Macrophage migration inhibitory factor elicits an angiogenic phenotype in human ectopic endometrial cells and triggers the production of major angiogenic factors via CD44, CD74, and MAPK signaling pathways. J Clin Endocrinol Metab 95(12), E403-412 (2010)
21. B Sun, J Nishihira, M Suzuki, N Fukushima, T Ishibashi, M Kondo, Y Sato, S Todo: Induction of macrophage migration inhibitory factor by lysophosphatidic acid: relevance to tumor growth and angiogenesis. Int J Mol Med 12(4), 633-641 (2003) [doi not found]
22. H Shimada, LE Rajagopalan: Rho-kinase mediates lysophosphatidic acid-induced IL-8 and MCP-1 production via p38 and JNK pathways in human endothelial cells. FEBS Lett 584(13), 2827-2832 (2010)
23. CI Lin, CN Chen, PW Lin, KJ Chang, FJ Hsieh, H Lee: Lysophosphatidic acid regulates inflammation-related genes in human endothelial cells through LPA1 and LPA3. Biochem Biophys Res Commun 363(4), 1001-1008 (2007) (Pubitemid 47552970)
24. H Lee, CI Lin, JJ Liao, YW Lee, HY Yang, CY Lee, HY Hsu, HL Wu: Lysophospholipids increase ICAM-1 expression in HUVEC through a Gi- and NF-kappaBdependent mechanism. Am J Physiol Cell Physiol 287(6), C1657-1666 (2004) (Pubitemid 39507683)
25. H Shimada, LE Rajagopalan: Rho kinase-2 activation in human endothelial cells drives lysophosphatidic acid -mediated expression of cell adhesion molecules via NFkappaB p65. J Biol Chem 285(17), 12536-12542 (2010)
26. B Ren, J Hale, S Srikanthan, RL Silverstein: Lysophosphatidic acid suppresses endothelial cell CD36 expression and promotes angiogenesis via a PKD-1- dependent signaling pathway. Blood 117(22), 6036-6045 (2011)
27. RL Silverstein, M Febbraio: CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior. Sci Signal 2(72), re3 (2009)
28. Y Fujiwara, V Sardar, A Tokumura, D Baker, K Murakami-Murofushi, A Parrill, G Tigyi: Identification of residues responsible for ligand recognition and regioisomeric selectivity of lysophosphatidic acid receptors expressed in mammalian cells. J Biol Chem 280(41), 35038-35050 (2005) (Pubitemid 41504639)
29. F Gobeil, Jr., SG Bernier, A Vazquez-Tello, S Brault, MH Beauchamp, C Quiniou, AM Marrache, D Checchin, F Sennlaub, X Hou, M Nader, G Bkaily, A Ribeiro-da-Silva, EJ Goetzl, S Chemtob: Modulation of pro-inflammatory gene expression by nuclear lysophosphatidic acid receptor type-1. J Biol Chem 278(40), 38875-38883 (2003) (Pubitemid 37221787)
30. R Kou, J Igarashi, T Michel: Lysophosphatidic acid and receptor-mediated activation of endothelial nitric-oxide synthase. Biochemistry 41(15), 4982-4988 (2002) (Pubitemid 34298666)
31. B Ren, J Hale, D Ramakrishnan, RL Silverstein: HDAC 7 Couples LPA Signaling to Endothelial Cell CD36 Gene Regulation to Switch off TSP-1 Mediated Antiangiogenic Responses. Circulation 122, A12757 (2010) [doi not found]
32. TM McIntyre, AV Pontsler, AR Silva, A St Hilaire, Y Xu, JC Hinshaw, GA Zimmerman, K Hama, J Aoki, H Arai, GD Prestwich: Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPARgamma agonist. Proc Natl Acad Sci U S A 100(1), 131- 136 (2003) (Pubitemid 36078041)
33. TS Panetti, H Chen, TM Misenheimer, SB Getzler, DF Mosher: Endothelial cell mitogenesis induced by LPA: inhibition by thrombospondin-1 and thrombospondin-2. J Lab Clin Med 129(2), 208-216 (1997) (Pubitemid 27134066)
34. Y Xing, SH Ganji, JW Noh, VS Kamanna: Cell densitydependent expression of EDG family receptors and mesangial cell proliferation: role in lysophosphatidic acid-mediated cell growth. Am J Physiol Renal Physiol 287(6), F1250-1257 (2004) (Pubitemid 39507234)
35. F Wang, JR Van Brocklyn, JP Hobson, S Movafagh, Z Zukowska-Grojec, S Milstien, S Spiegel: Sphingosine 1- phosphate stimulates cell migration through a G(i)-coupled cell surface receptor. Potential involvement in angiogenesis. J Biol Chem 274(50), 35343-35350 (1999) (Pubitemid 129512822)
36. Y Yatomi, T Ohmori, G Rile, F Kazama, H Okamoto, T Sano, K Satoh, S Kume, G Tigyi, Y Igarashi, Y Ozaki: Sphingosine 1-phosphate as a major bioactive lysophospholipid that is released from platelets and interacts with endothelial cells. Blood 96(10), 3431-3438 (2000) [doi not found]
37. HL Wu, CI Lin, YL Huang, PS Chen, CH Kuo, MS Chen, GC Wu, GY Shi, HY Yang, H Lee: Lysophosphatidic acid stimulates thrombomodulin lectinlike domain shedding in human endothelial cells. Biochem Biophys Res Commun 367(1), 162-168 (2008)
38. TS Panetti, J Nowlen, DF Mosher: Sphingosine-1- phosphate and lysophosphatidic acid stimulate endothelial cell migration. Arterioscler Thromb Vasc Biol 20(4), 1013- 1019 (2000) (Pubitemid 30207575)
39. A Yoshida, B Anand-Apte, BR Zetter: Differential endothelial migration and proliferation to basic fibroblast growth factor and vascular endothelial growth factor. Growth Factors 13(1-2), 57-64 (1996)
40. C Avraamides, ME Bromberg, JP Gaughan, SM Thomas, AY Tsygankov, TS Panetti: Hic-5 promotes endothelial cell migration to lysophosphatidic acid. Am J Physiol Heart Circ Physiol 293(1), H193-203 (2007) (Pubitemid 47105074)
41. MM Ptaszynska, ML Pendrak, ML Stracke, DD Roberts: Autotaxin signaling via lysophosphatidic acid receptors contributes to vascular endothelial growth factorinduced endothelial cell migration. Mol Cancer Res 8(3), 309-321 (2010)
42. L Jakobsson, CA Franco, K Bentley, RT Collins, B Ponsioen, IM Aspalter, I Rosewell, M Busse, G Thurston, A Medvinsky, S Schulte-Merker, H Gerhardt: Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting. Nat Cell Biol 12(10), 943-953 (2010)
43. CM Rivera-Lopez, AL Tucker, KR Lynch: Lysophosphatidic acid (LPA) and angiogenesis. Angiogenesis 11(3), 301-310 (2008)
44. MM Muller, BB Singer, E Klaile, B Obrink, L Lucka: Transmembrane CEACAM1 affects integrin-dependent signaling and regulates extracellular matrix protein-specific morphology and migration of endothelial cells. Blood 105(10), 3925-3934 (2005) (Pubitemid 40656138)
45. N Ferrara, KJ Hillan, HP Gerber, W Novotny: Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat Rev Drug Discov 3(5), 391-400 (2004) (Pubitemid 38618122)
46. AK Olsson, A Dimberg, J Kreuger, L Claesson-Welsh: VEGF receptor signalling - in control of vascular function. Nat Rev Mol Cell Biol 7(5), 359-371 (2006)
47. ES Jeon, SC Heo, IH Lee, YJ Choi, JH Park, KU Choi, Y Park do, DS Suh, MS Yoon, JH Kim: Ovarian cancerderived lysophosphatidic acid stimulates secretion of VEGF and stromal cell-derived factor-1 alpha from human mesenchymal stem cells. Exp Mol Med 42(4), 280-293 (2010)
48. A Sako, J Kitayama, D Shida, R Suzuki, T Sakai, H Ohta, H Nagawa: Lysophosphatidic acid (LPA)-induced vascular endothelial growth factor (VEGF) by mesothelial cells and quantification of host-derived VEGF in malignant ascites. J Surg Res 130(1), 94-101 (2006) (Pubitemid 43028570)
49. Y Song, J Wu, RA Oyesanya, Z Lee, A Mukherjee, X Fang: Sp-1 and c-Myc mediate lysophosphatidic acidinduced expression of vascular endothelial growth factor in ovarian cancer cells via a hypoxia-inducible factor-1- independent mechanism. Clin Cancer Res 15(2),492-501 (2009)
50. X Hu, FJ Mendoza, J Sun, V Banerji, JB Johnston, SB Gibson: Lysophosphatidic acid (LPA) induces the expression of VEGF leading to protection against apoptosis in B-cell derived malignancies. Cell Signal 20(6):1198- 1208 (2008)
51. ES Jeon, IH Lee, SC Heo, SH Shin, YJ Choi, JH Park, Y Park do, JH Kim: Mesenchymal stem cells stimulate angiogenesis in a murine xenograft model of A549 human adenocarcinoma through an LPA1 receptor-dependent mechanism. Biochim Biophys Acta 1801(11), 1205-1213 (2010)
52. W Kalas, P Klement, J Rak: Downregulation of the angiogenesis inhibitor thrombospondin 1 in fibroblasts exposed to platelets and their related phospholipids. Biochem Biophys Res Commun 334(2), 549-554 (2005) (Pubitemid 40982401)
53. B Ren, K Song, S Parangi, T Jin, M Ye, R Humphreys, M Duquette, X Zhang, N Benhaga, J Lawler, R Khosravi- Far: A double hit to kill tumor and endothelial cells by TRAIL and antiangiogenic 3TSR. Cancer Res 69(9), 3856- 3865 (2009)
54. ML Stracke, HC Krutzsch, EJ Unsworth, A Arestad, V Cioce, E Schiffmann, LA Liotta: Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein. J Biol Chem 267(4), 2524-2529 (1992) [doi not found]
55. MM Ptaszynska, ML Pendrak, RW Bandle, ML Stracke, DD Roberts: Positive feedback between vascular endothelial growth factor-A and autotaxin in ovarian cancer cells. Mol Cancer Res 6(3), 352-363 (2008) (Pubitemid 351416526)
56. E Im, R Motiejunaite, J Aranda, EY Park, L Federico, TI Kim, T Clair, ML Stracke, S Smyth, A Kazlauskas: Phospholipase Cgamma activation drives increased production of autotaxin in endothelial cells and lysophosphatidic acid-dependent regression. Mol Cell Biol 30(10), 2401-2410 (2010)
57. AG Linkous, EM Yazlovitskaya, DE Hallahan: Cytosolic phospholipase A2 and lysophospholipids in tumor angiogenesis. J Natl Cancer Inst 102(18), 1398-1412 (2010)
58. G Tosato, M Segarra, O Salvucci: Cytosolic phospholipase A2{alpha} and cancer: a role in tumor angiogenesis. J Natl Cancer Inst 102(18), 1377-1379 (2010)
59. X Xu, GD Prestwich: Inhibition of tumor growth and angiogenesis by a lysophosphatidic acid antagonist in an engineered three-dimensional lung cancer xenograft model. Cancer 116(7), 1739-1750 (2010)
60. G Tigyi: Aiming drug discovery at lysophosphatidic acid targets. Br J Pharmacol 161(2), 241-270 (2010)
61. S Ishii, K Noguchi, K Yanagida: Non-Edg family lysophosphatidic acid (LPA) receptors. Prostaglandins Other Lipid Mediat 89(3-4),57-65 (2009)
62. S Oka, R Ota, M Shima, A Yamashita, T Sugiura: GPR35 is a novel lysophosphatidic acid receptor. Biochem Biophys Res Commun 395(2), 232-237 (2010)
63. S Muehlich, N Schneider, F Hinkmann, CD Garlichs, M Goppelt-Struebe: Induction of connective tissue growth factor (CTGF) in human endothelial cells by lysophosphatidic acid, sphingosine-1-phosphate, and platelets. Atherosclerosis 175(2), 261-268 (2004) (Pubitemid 38942906)
64. F Gobeil, Jr., T Zhu, S Brault, A Geha, A Vazquez- Tello, A Fortier, D Barbaz, D Checchin, X Hou, M Nader, G Bkaily, JP Gratton, N Heveker, A Ribeiro-da-Silva, K Peri, H Bard, A Chorvatova, P D'Orleans-Juste, EJ Goetzl, S Chemtob: Nitric oxide signaling via nuclearized endothelial nitric-oxide synthase modulates expression of the immediate early genes iNOS and mPGES-1. J Biol Chem 281(23), 16058-16067 (2006) (Pubitemid 43848500)